J. Philip Miller Research Lab

Bibliography

Jack Baty

  1. Lipfert FW, Wyzgab RE, Baty JD, Miller JP. Traffic density as a surrogate measure of environmental exposures in studies of air pollution health effects: Long-term mortality in a cohort of US veterans. Atmospheric Environment, 40:154:169, 2006.
  2. Lagroye I, Hook GJ, Wettering BA, Baty JD, Moros EG, Straube WL, Roti Roti JL. Measurements of alkali-labile DNA damage and protein-DNA crosslinks after 2450 MHz microwave and low-dose gamma irradiation in vitro. Radiation Research, 161:201-214, 2004.
  3. Hook GJ, Zhang P, Lagroye I, Li L, Higashikubo R, Moros EG, Straube WL, Pickard WF, Baty JD, Roti Roti JL. Measurement of DNA damage and apoptosis in molt-4 cells after in vitro exposure to radiofrequency radiation. Radiation Research, 161:193-200, 2004.
  4. Woodward RS, Schnitzler MA, Baty JD, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. American Journal of Transplantation, 3:590-598, 2003.
  5. Lowe JB 3rd, Lowe JB, Baty JD, Garza JR. Risks associated with "components separation" for closure of complex abdominal wall defects. Plastic & Reconstructive Surgery, 111:1276-1283, 2003.
  6. Lipfert FW, Perry HM, Miller JP, Baty JD, Wyzga RE, Carmody SE. Air pollution, blood pressure and their long-term associations with mortality. Inhalation Toxicology, 15:493-512, 2003.
  7. La Regina M, Moros EG, Pickard WF, Straube WL, Baty JD, Roti Roti JL. The effect of chronic exposure to 835.62 MHz FDMA or 847.74 MHz CDMA radiofrequency radiation on the incidence of spontaneuos tumors in rats. Radiation Research, 160:143-151, 2003.
  8. Kheem S, Moros EG, Straube WL, Baty JD, Roti Roti JL. The effect of 835.62 MHz FDMA or 847.74 MHz CDMA modulated radiofrequency radiation on the induction of micronuclei in C3H 10T1/2 Cell. Radiation Research, 157:506-515, 2002.
  9. Schechtman KB, Gray DL Baty JD, Torhman SM. Decision-making for termination of pregnancies with fetal anomalies: Analysis of 53,000 pregnancies. Obstetrics & Gynecology, 99(2):216-222, 2002.
  10. Perry HM, Miller JP, Baty JD, Wyzga RE, Carmody SE. The Washington University-EPRI veterans' cohort mortality study: Preliminary results. Inhalation Toxicology, 12(Supplement 4):41-73, 2000.
  11. White DA, Baty JD, Buckles VD, Choi J, Gado M, Perry HM, Powers W, Morris JC. Differential patterns of neurocognitive impairment in individuals with systolic hypertension, carotid occlusion, and dementia of the Alzheimer type. Neurology, 52:A97-98, 1999.
  12. Mortimer JE, Boucher L, Baty JD, Knapp DL, Ryan E, Rowland JH. Effect of tamoxifen on sexual functioning in patients with breast cancer. Journal of Clinical Oncology, 17:1488-1492, 1999.
  13. Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology, 53:956-962, 1999.
  14. Vogler C, Levy B, Galvin NJ, Thorpe C, Sands MS, Barker JE, Baty JD, Birkenmeier EH, Sly WS. Enzyme replacement in murine mucopolysaccharidosis type VII: Neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy. Pediatric Research, 45:838-844, 1999.
  15. Smith MC, Goldman WP, Janer KW, Baty JD, Morris JC. Cognitive speed in nondemented Parkinson?s disease. Journal of the International Neuropsychological Society, 4:584-592, 1998.
  16. Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC. Cognitive and motor functioning in Parkinson disease. Archives of Neurology, 55:674-680, 1998.
  17. Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM. Clinicopathologic studies in cognitively healthy aging and alzheimer disease. Archives of Neurology, 55:326-335, 1998.
  18. Brennan DC, Schnitzler MA, Baty JD, Ceriotti CS, Lowell JA, Shenoy S, Howard TK, Woodward RS. A pharmacoeconomic comparison of antithymocyte globulin and muromomab CD3 induction therapy in renal transplant recipients. Pharmacoeconomics, 11:237-245, 1997.
  19. Haug JS, Todd G, Baty JD, Bremer R, Link D, DiPersio JF. The baseline levels of CD34+ lineage cells and platelet counts in autologous patients predict the yield of PBSC collections. Blood, 90:930, 1997.
  20. Wedner HJ, Gandhi R, Baty JD, Dixit A. Statistical analysis of epicutaneous skin test reactivity to seasonal and perennial allergens. Journal of Allergy and Clinical Immunology, 99:620, 1997.
  21. Luker GD, Siegel MJ, Bradley DA, Baty JD. Hepatic spiral CT in children: Scan delay time-enhancement analysis. Pediatric Radiology, 26:337-40, 1996.
  22. Scholnick SB, Haughey BH, Sunwoo JB, El-Mofty SK, Baty JD, Piccirillo JF, Zequeira MR. Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx. Journal of the National Cancer Institute, 88(22):1676-1682, 1996.
  23. Perry HM, Miller JP, Fornoff JR, Baty, JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension, 25(4):587-594, 1995.
  24. Humphrey PA, Baty JD and Keetch D. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Supplement to Cancer, 75(7):1842-1849, 1995.
  25. Humphrey PA, Baty JD and Keetch D. Carcinoma extent in needle biopsies and matched quadrants in radical prostatectomy specimens. Laboratory Investigation, 72:A78, 1995.
  26. Berg L, McKeel DW, JP Miller, Baty JD, Morris JC. Neuropathological indexes of Alzheimer's disease in demented and nondemented people aged 80 and over.Archives of Neurology, 50:349-358, 1993.
  27. Berg L, Miller JP, Baty JD, Rubin EH, Morris JC, Figiel G. Mild senile dementia of the Alzheimer Type: 4. Evaluation of intervention. Annals of Neurology, 31:242-249, 1992.
  28. Florence JM, Pandya S, King WM, Robison JD, Baty JD, Miller JP, Schierbecker J, Signore LC. Intrarater reliability of manual muscle test (Medical Research Council Scale) grades in Duchenne's Muscular Dystrophy. Physical Therapy, 72:115-123, 1992.
  29. Florence JM, Pandya S, King WM, Robison JD, Schierbecker J, Matheson N, Baty JD, Miller JP, the CIDD Group. The utility of the MMT and myometry in DMD. APTA Annual Conference, Boston, MA. 1991. Abstract.
  30. Griggs RC, Moxley RT, Pandya S, Mendell JR, King WM, Signore L, Fenichel GM, Robison JR, Brooke MH, Matheson NJ, Miller JP, Wilson B, Baty J. Randomized controlled trial of Prednisone and Azathiprine in Duchenne Dystrophy. American Academy of Neurology, 1991. Abstract.

Feng Gao

  1. Gao F, Thompson P, Xiong C, Miller JP. Analyzing Multivariate Longitudinal Data Using SAS. Proceedings of the SAS? Users Group International (SUGI 31) Conference, San Francisco, California, March, 2006.
  2. Gao S, Shen P, Gao F. The regional cerebral blood flow of elderly with transient ischemic attack. Chinese Journal of Geriatrics, 1992, 11(3):149-151.
  3. Gao S, Li W, Wu X, Dai S, Gao F, Sun K. The contribute factors of intellectual disorders in epileptic patients. National Medical Journal of China, 1993, 73(3):161-162.
  4. Du J, Ai Y, Li S, Zhang Q, Gao F. Stepwise regression analysis of electrocardiographic findings in pneumonia of infants and children. Chinese Journal of Pediatrics, 1993, 31(1):15.
  5. Gao F, Wang R, Han D, Sun K. Application of Cox model in prognosis of radical larngectomy laryngeal carcinoma cases. Chinese Journal of Preventive Medicine, 1995, 29(6):367.
  6. Guo Y, Wen H, Gao F, Cao Z. The study of estrogen and progesterone receptors in ovarian cancer. Journal of Beijing Medical University, 1995, 27(5):371-373.
  7. Gao F, Sun K, Guo Y. Application of Cox model in the follow-up data. Chinese Journal of Oncology, 1997, 19(3):202.
  8. Huang M, Ma D, Sun K, Yu G, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. International Journal of Oral and Maxillofacial Surgery, 1997, 26:435-439.
  9. Xu B, Yin X, Huang Y, Gao F. The comparison of static posturgraphy in subjects with healthy backs and chronic low back pain. Chinese Journal of Rehabilitation Theory & Practice, 1997, 3(2):62-65.
  10. Xu B, Yin X, Huang Y, Gao F. The static posturgraphy of different sex, age healthy subjects. Journal of Beijing Medical University, 1997, 29(2):30.
  11. Gao F, Peng K, Wang R. Application of receiver operating characteristic curve to evaluate myocardial enzymes' effects on identification of acute myocardial infarction. Journal of Beijing Medical University, 1998, 30(4):345-347.
  12. Musselman DL, Miller AH, Porter MR, Manatunga AK, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB. Higher than normal plasma interleukin-6 concentration in cancer patients with depression: Preliminary finding. American Journal of Psychiatry, 2001, 158:1252-1257.
  13. Musselman DL, Marzec U, Davidoff M, Manatunga AK, Gao F, Reemsnyder A, Duggirala S, Larsen H, Taylor RW, Hanson S, Nemeroff CB. Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment. Depression and Anxiety, 2002, 15:91-101.
  14. Wright JD, Pinto AB, Powell MA, Lu DW, Gao F, Pinto KR. Atypical Squamous Cells of Undetermined Significance in in girls and women. Obstetrics Gynecology, 2004, 103:632-8.
  15. Xiong C, Miller JP, Gao F, Yan Y, Morris JC. Testing increasing hazard rate for the progression time of dementia. Discrete and Continuous Dynamical Systems ? Series B, 2004, 4:813-821.
  16. Gao F, Manatunga AK, Chen S. Identification of prognostic factors for multivariate survival data. Computational Statistics and Data Analysis, 2004, 45:813-824.
  17. Wright JD, Powell MA, Herzog TJ, Mutch DG, Rader JS, Gao F, Gibb RK. Panniculectomy: Improving Lymph Node Yield in the Morbidly Obese Patient with Endometrial Cancer. Gynecologic Oncology, 2004, 94:436-441.
  18. Kommareddy A, Coplin MA, Gao F, Trinkaus K, Behnken D, Romvari E, Read W, Govindan R. Gefitinib use as a single agent first line therapy in patients with advanced Non Small Cell Lung Cancer: An Institutional experience. Lung Cancer (in press, 2004).

Betsy Grant

  1. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal Course and Neuropathological Outcomes in Original vs Revised MCI and in PreMCI. Neurology, in press.
  2. Galvin, JE, Powlishta, KK, Wilkins, K, McKeel, DW, Storandt, M, Grant, EA, Morris, JC. Predictors of dementia in older adults followed longitudinally to autopsy. Archives of Neurology, 2004 (in press).
  3. McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L and Morris JC. Neuropathologic Criteria For Diagnosing Alzheimer's Disease in Persons with Pure Dementia of Alzheimer Type. Journal of Neuropathology and Experimental Neurology (JNEN), 2004;63(10):1028-1037.
  4. Powlishta, KK, Storandt, M, Mandenach, TA, Hogan, E, Grant, EA, Morris, JC. Absence of effect of depression on cognitive performance in early stage Alzheimer's disease. Archives of Neurology, 2004;61:1265-1268.
  5. Cacchione PZ, Powlishta KK, Grant EA, Buckles VD, Morris JC. Accuracy of Collateral Source Reports in Very Mild to Mild Dementia of the Alzheimer Type. Journal of the American Geriatrics Society, 2003;51:819-823.
  6. Villareal DT, Grant E, Miller JP, Storandt M, Morris JC. Clinical Outcomes of Possible Versus Probable Alzheimer's Disease. Neurology, 2003;61:661-667.
  7. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer disease. Neurology, 2002;59:1034-1041.
  8. Goldman WP, Price JL, Storandt M, Grant EA, McKeel Jr DW, Rubin EH, Morris JC. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology, 2001;56:361-367.
  9. Morris JC, Hurst E, McKeel DW, Price JL, Rubin E, Grant EA, Berg L. Healthy brain aging in nonagenarians and centenarians. Neurobiol Aging, 2000;21(1S):S280-S281.
  10. Hellman NE, Grant EA, Goate AM. Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: An Association Study. Ann Neurol, 1998;44: 278-281.
  11. Rubin E, Storandt M, Miller JP, Kinscherf DA, Grant EA, Mansr JC, and Berg L. A prospective study of cognitive function and onset of dementia in cognitively healthy elder. Arch Neurol, 1998;55:395-401.
  12. Mayeux RH, Sauders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang M-X, Phelps CH for the ADC Consortium on Apolipoprotein E and Alzheimer's Disease. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med,1998;338:506-511
  13. Edwards DF, Reyner AV, Applegate C, Grant EA, Morris JC. Increased burden in caregivers of rural elders with Alzheimer's disease: A comparative study of functional impairment and service needs. J Gerontol, 1998.
  14. Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA and Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology, 1996;46:707-719
  15. Rubin EH, Storandt M, Miller JP, Grant EA, Kinscherf DA, Morris JC and Berg L. Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type. Archives of Neurology, 1993;50:380-383.
  16. Morris JC, McKeel DW, Storandt M, Rubin EH, Price JL, Grant EA, Ball MJ and Berg L. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology, 1991;41:469-478.
  17. Wippold FJ, Gado M, Morris JC, Duchek J and Grant EA. Senile dementia and healthy aging: A longitudinal CT study. Radiology, 1991;179:215-219.
  18. Rubin, EH, Kinscherf DA, Grant EA and Storandt M. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type. American Journal of Psychiatry. 1991;148:1164:1171.
  19. Davis PB, Morris JC, and Grant EA. Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc, 1990;38:129-135.
  20. McCulla MM, Coats M, Van Fleet N, Duchek J, Grant EA, and Morris JC. Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol, 1989;46:1210-1211.
  21. Morris JC, Drazner M, Fulling K, Grant EA, and Goldring J. Clinical and pathological aspects of Parkinsonism in Alzheimer's disease: A role for extranigral factors? Arch Neurol, 1989;46:651-657.
  22. Rubin EH, Morris JC, Grant EA, and Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical Assessment. Arch Neurol1989;46:379-382.
  23. Morris JC, Gado MH, Grant EA and Rezek DL. Periventricular white matter lucencies: no effect on the natural history of senile dementia of the Alzheimer type (SDAT). Ann Neurol, 1988;24:159 (Abs).
  24. Baum C, Edwards DF, Leavitt K, Grant EA, and Deuel R. Performance components in Senile Dementia of the Alzheimer Type: Motor planning, language, and memory. Occup Ther J Res, 1988;8:356-368.
  25. Storandt M, Grant EA, and Gordon BC. Remote memory as a function of age and sex. Exp Aging Res, 1978;4:365-375.
  26. Grant EA, Storandt M, and Botwinick J. Incentive and practice in the psychomotor performance of the elderly. J Geron, 1978;33:413-415.

Phil Miller

  1. Roe C, Xiong C, Miller JP, Cairns N, Morris J. Interaction of Neuritic Plaques and Education Predicts Dementia. Alzheimer Disease & Associated Disorders, in press.
  2. Miller DK, Wolinsky FD, Andresen EM, Malmstrom TK, Miller JP. Adverse outcomes and correlates of change in the Short Physical Performance Battery (SPPB) over 36 months in the African American Health project. J Gerontol: Medical Sciences, 62A, in press.
  3. Wolinsky FD, Miller TR, Malmstrom TK, Miller JP, Schootman M, Andresen EM, Miller DK. Self-rated health: changes, trajectories, and their antecedents among African Americans. J Aging and Health, 20(2):143-158, 2008.
  4. Andreson EM, Malmstrom TK, Wolinsky FD, Schootman M, Miller JP, Miller DK. Rating Neighborhoods for Older Adult Health: Results from the African American Health Study. BMC Public Health, 8:35, 2008.
  5. Xiong C, Tang Y, van Belle G, Miller JP, Launer LJ and Morris JC. Evaluating the Quality of Longitudinal statistical Applications in Original Publications on Alzheimer's Disease. Methods in Neuroepidemiology. 30:112-119, 2008.
  6. Wolf SL, Winstein CJ, Miller JP, Thompson PA, Taub E, Uswatte G, Morris D, Blanton S, Nichols-Larsen D, Clark PC. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol, 7:33-40, 2008.
  7. Roe CM, Xiong, Miller JP, Morris JC. Education and Alzheimer's Disease without Dementia. Support for the Cognitive Reserve Hypothesis. Neurology, 68:223-228., 2007.
  8. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Kraisthith A, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, and the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic Resonance Measurements of Renal Blood Flow and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology, Clin J Am Soc Nephrol, 2:112-120, 2007.
  9. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Yan Y, Miller DK. The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans. American Journal of Epidemiology, 166(4):379-387, 2007.
  10. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP, Miller DK. Neighborhood environment and the incidence of depressive symptoms among middle-aged African Americans. J Epidemiol Community Health, 61(6):527-532, 2007.
  11. Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group (Writing Committee:Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA). Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular Hypertension. Ophthalmology, 114:10-19, 2007.
  12. Malmstrom TK, Andresen EM, Wolinsky FD, Miller JP, Stamps K, Miller DK. Mortality risk in older inner-city African Americans. Journal of the American Geriatrics Society, 55:1049-1055, 2007.
  13. Xiong C, van Belle G, Miller JP, Yan Y, Gao F, Yu K, Morris JC. A parametric comparison of diagnostic accuracy with three ordinal diagnostic groups. Biometrical Journal, 49(5):682-693, 2007.
  14. Rosetti S, Consugar M, Chapman A, Torres V, Guay-Woodford L, Grantham J, Bennett W, Meyers C, Walker D, Bae K, Zhang Q, Thompson P, Miller JP, Harris P, CRISP Consortium. Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol, 18:2143-2160, 2007.
  15. Wolinsky FD, Miller TR, Malmstrom TK, Miller; JP, Schootman M, Andresen EM, Miller DK. Four-Year Lower Extremity Disability Trajectories Among African American Men and Women. J Gerontol: Medical Sciences, 62A(5):525-530, 2007.
  16. Xiong C, Tang Y, van Belee G, Miller JP, Launer LJ, Bergmann KR, Morris JC. Assessing Statistical Applications in Publications on Alzheimer's Disease. Neuroepidemiology, 28:235-245, 2007.
  17. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP, Miller TR. The Effect of Sub-Clinical Status in Functional Limitation and Disability on Adverse Health Outcomes Three Years Later. Journal of Gerontology: Medical Sciences, 62A(1):101-106, 2007.
  18. Wolf SL, Winstein C, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light K, Nichols-Larsen D. Effect of Constraint Induced Movement Therapy on Upper Extremity Function among Patients 3-9 Months Following Stroke: The EXCITE Randomized Clinical Trial. Journal of the American Medical Association, 296(17):2095-2104, 2006.
  19. Bae K, Zhu F, Chapman A, Torres V, Grantham J, Guay-Woodford L, Baumgarten D, King BF, Wetzel LH, Kenney P, Brummer M, Bennett W, Klahr S, Meyers C, Zhang X, Thompson P, Miller J. Magnetic Resonance Imaging (MRI) Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Clinical Journal of American Society of Nephrology, 1:64-69, 2006.
  20. Kymes SM, Kass MA, Anderson D, Miller JP, Gordon MO for the OHTS Study Group (OHTS). Management of patients with ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study (OHTS). American Journal of Ophthalmology, 141(6):997-1008, 2006.
  21. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal Course and Neuropathological Outcomes in Original vs Revised MCI and in PreMCI. Neurology, 67:467-473, 2006.
  22. Xiong C, van Belle G, Miller JP, Morris JC. Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups. Statistics in Medicine, 25:1251-1273, 2006.
  23. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, for the CRISP Investigators. Volume Progression in Polycystic Kidney Disease. N Engl J Med, 354(20):2122-2130, 2006.
  24. Gao F, Thompson P, Xiong C, Miller JP. Analyzing Multivariate Longitudinal Data Using SAS. Proceedings of the SAS? Users Group International (SUGI 31) Conference, San Francisco, California, March, 2006.
  25. Miller DK, Andresen EM, Malmstrom TK, Miller JP, Wolinsky FD. Test-Retest Reliability of Subclinical Status for Functional Limitation and Disability. Journal of Gerontology: Social Sciences, 61B(1):S52-S56, 2006.
  26. Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP, for the CRISP Consortium. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. J Amer Society Nephrology, 17(3):854 - 862, 2006 (http://jasn.asnjournals.org/cgi/rapidpdf/ASN.2005070697v1.pdf).
  27. Lipfert FW, Wyzgab RE, Baty JD, Miller JP. Traffic density as a surrogate measure of environmental exposures in studies of air pollution health effects: Long-term mortality in a cohort of US veterans. Atmospheric Environment, 40:154:169, 2006.
  28. Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC. Neuroanatomical Predictors of Response to Donepezil in Dementia Patients. Archives of Neurology, 62:1718-1722, 2005.
  29. Wolf SW, Thompson PA, Taub E, Uswatte G, Miller JP, and the EXCITE Group. The EXCITE trial: Baseline attributes of the Wolf Motor Function Test in Patients with sub-acute stroke. Neurorehabilitation and Neural Repair, 19(3):194-205, 2005.
  30. Wilson M-MG, Miller DK, Andresen EM, Malmstrom TK, Miller JP, Wolinsky FD: Fear of Falling and Related Activity Restriction Among Middle Aged African Americans. J Gerontology: Medical Sciences, 60A(3):355-360, 2005.
  31. Miller DK, Wolinsky FD, Malmstrom TK, Andresen EM, Miller JP. Inner City Middle Aged African Americans Have Excess Frank and Subclinical Disability. Journal of Gerontology: Medical Sciences, 60A:207-212, 2005.
  32. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, Miller JP, Storandt M, Morris JC. The AD8: A brief informant interview to detect dementia. Neurology, 65:559-564, 2005.
  33. Malmstrom, TK, Wolinsky, FD, Andresen, EM, Miller, PM, Miller, DK. Cognitive Ability and Physical Performance in Middle Aged African Americans. J Am Geriatrics Society, 53:997-1001, 2005.
  34. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP.? Further Evidence for the Importance of Sub-Clinical Functional Limitation and Sub-Clinical Disability Assessment in Gerontology and Geriatrics.? Journal of Gerontology: Social Sciences, 60B(3):S146-S151, 2005.
  35. Fisher E, Musick J, Scott C, Miller JP, Gram R, Richardson V, Clark J, Pachalla. Improving Clinic- and Neighborhood-Based Smoking Cessation Services within Federally Qualified Health Centers Serving Low-Income, Minority Neighborhoods. Nicotine & Tobacco Research, 7 (Supplement 2):S1-S12, 2005.
  36. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP. Reproducibility of Physical Performance and Physiologic Assessments. Journal of Aging and Health, 17(2):111-124, 2005.
  37. Andresen EM, Malmstrom TK, Miller DK, Miller JP, Wolinsky FD. Retest Reliability of Self-Reported Function, Self-Care, and Disease History. Medical Care, 43(1):93-97, 2005.
  38. McKeel DW Jr, Price JL, Miller JP, Grant EA, Xiong C, Berg L, Morris JC. Neuropathologic Criteria for Diagnosing Alzheimer's Disease in Persons with Pure Dementia of Alzheimer Type. Journal of Neuropathology and Experimental Neurology (JNEN), 63(10):1028-1037, 2004.
  39. Shah KR, Carr D, Roe CM, Miller JP, Coats M, Morris JC. Impaired Physical Performance and the Assessment of Dementia of the Alzheimer Type. Alzheimer Disease and Associated Disorders, 18(3):112-119, 2004.
  40. Xiong C, Miller JP, Feng G, Yan Y, Morris JC. Testing for Increasing Hazard Rate for the Time of Progression associated with Alzheimer's Disease. Discrete and Continuous Dynamical Systems-Series B, 4(3):813-821, 2004.
  41. Wolinsky FD, Miller DK, Andresen EM, Malmstrom TK, Miller JP. Health Related Quality of Life in Middle Aged African Americans. Journal of Gerontology, 59B(2):S118-S123, 2004.
  42. Xiong C, Miller JP, Yan Y, Ji M. Effect of a Guarantee Time on Sample Size Determination for Testing the Ratio of Means from Two Lifetime Distributions. Journal of Biopharmaceutical Statistics, 14(1):177-188, 2004.
  43. Xiong C, Miller JP, Morris JC. Testing Correlation of Cognitive Decline at Adjacent Stages of Dementia. Journal of Alzheimer's Disease, Xiong C, Miller JP, Morris JC. Testing Correlation of Cognitive Decline at Adjacent Stages of Dementia. Journal of Alzheimer's Disease, 5:409-418, 2003.
  44. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grangham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic Resonance Measurements of Renal Blood Flow as a Marker of Disease Severity in Autosomal Dominant Polycystic Kidney Disease. Kidney International, 64:2214-2221, 2003.
  45. Miller JP, Schauer J, Baty JD, Littlewood S, Trinkaus K, Lill RM, Richards R. Managing Clinical Trials Data with a SAS-Based Web Portal. Proceedings of the 2003 SAS Users Group International, April, 2003.
    (also at http://www.biostat.wustl.edu/~phil/stuff/SCIP%20Paper.pdf)
  46. Winstein CJ, Miller JP, Blanton SB, Morris D, Uswatte G, Taub E, Nichols D, Wolf S. Methods for a Multi-site Randomized Trial to Investigate the Effect of Constraint-Induced Movement Therapy in Improving Upper Extremity Function Among Adults Recovering from a Cerebrovascular Stroke. Neurorehabilitation and Neural Repair, 17(3):137-152, 2003.
  47. Villareal DT, Grant E, Miller JP, Storandt M, Morris JC. Clinical Outcomes of Possible Versus Probable Alzheimer's Disease. Neurology, 61:661-667, 2003.
  48. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O?Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP. Renal Structure in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney International, 64:1035-1045, 2003.
  49. Lipfert FW, Perry HM Jr, Miller JP, Baty JD, Wyzga RE, Carmody SE: Air Pollution, Blood Pressure, and Their Long-Term Associations with Mortality. Inhalation Toxicology, 15:493-512, 2003.
  50. Storandt M, Grant EA, Miller JP, Morris JC. Rates of Progression in Mild Cognitive Impairment and Early Alzheimer's Disease. Neurology, 59:1034-1041, 2002.
  51. Powlishta KK, Von Dras DD, Stanford A, Carr DB, Tsering C, Miller JP, Morris JC. The Clock Drawing Test is a Poor Screen for Very Mild Dementia. Neurology, 59:898-903, 2002.
  52. Ory MG, Lipman PD, Karlen PL, Gerety MB, Stevens VJ, Fiatarone Singh MA, Buchner DM, Schechtman KB, The FICSIT Group. Recruitment of Older Participants in Frailty/Injury Prevention Studies. Prevention Science, 3(1):1-22, 2002.
  53. Csernansky JG, Miller JP, McKeel D, Morris JC. Relationships Among Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer Type. Alzheimer Disease and Associated Disorders, 16(3):144-149, 2002.
  54. Feuer WJ, Parrish RK, Schiffman JC, Anderson DR, Budenz DL, Wells MC, Hess DJ, Kass MA, Gordon MO and the Ocular Hypertension Treatment Study Group. The Ocular Hyppertension Treatment Study: Reproducibility of Cup/Disk Ratio Measurements Over Time at an Optic Disc Reading Center. Am J Opthalmol, 133:19-28, 2002.
  55. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Kass MA for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Baseline Factors that Predict the Onset of Primary Open-Angle Glaucoma. Arch Opthalmol, 120:714-720, 2002.
  56. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: A Randomized Trial Determines that Topic Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle Glaucoma. Arch Opthalmol, 120:701-713, 2002.
  57. Trinkaus KM, Miller JP. Principles of Clinical Trials. In: The Washington Manual of Oncology, Govindan R, Arquette M (eds). Lippincott, Philadelphia, 2002, pp. 1-10.
  58. Thompson PA, Littlewood S, Adelman AJ, Miller JP. The Web Data Entry System: Methods for Web Development and SAS Data Management. Proceedings of the SAS Users Group International, April, 2002.
  59. Binder EF, Miller JP, Ball LJ. Development of a Test of Physical Performance for the Nursing Home Setting (NHPPT). Gerontologist, 41:671-9, 2001.
  60. Lin SP, Song SK, Miller JP, Ackerman JJH, Neil JJ. A direct, longitudinal comparison of 1H and 23Na MRI following transient focal cerebral ischemia. Stroke, 32:925-32, 2001.
  61. Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT. Clinicopathologic Assessment and Grading of Embolized Meningiomas: A Correlative Study of 64 Patients. Cancer, 92:701-11, 2001.
  62. Morris JC, Storandt M, Miller JP, McKeel, Jr DW, Price JP, Rubin EH, Berg L. Mild Cognitive Impairment Represents Early-Stage Alzheimer's Disease. Archives of Nerology, 58:397-405, 2001.
  63. Luhmann JD, Kennedy RM, Porter FL, Miller JP, Jaffe, DM. A Randomized Clinical Trial of Continuous Flow Nitrous Oxide and Midazolam for Sedation of Young Children during Laceration Repair. Annals of Emergency Medicine, 37:20-27, 2001.
  64. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI. Early DAT is Distinguished from Aging by High Dimensional Mapping of the Hippocampus. Neurology, 55:1636-43, 2000.
  65. Lipfert FW, Perry HM, Jr., Miller JP, Baty JD, Wyzga RE, Carmody SE. The Washington University-EPRI Veterans' Cohort Mortality Study: Preliminary Results. Inhalation Toxicology, 12:41-73, 2000.
  66. Keltner JL, Johnso CA, Quigg JM, Cello KE, Mass MA, Gordon MA for the Ocular Hypertension Study Group. Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment Study (OHTS). Archives of Ophthalmology, 118:1187-94, 2000.
  67. Farber NB, Rubin EH, Newcomer JW, Kinscherf DA, Miller JP, Morris JC, Olney JW, McKeel DW. Increased Neocortical Neurofibrillary Tangle Density in Subjects with Alzheimer's Disease and Psychosis. Archives of General Psychiatry, 57:1165-73, 2000.
  68. Trinkaus KM, Thompson PA, Miller JP. Using SAS/IntrNet Software to Support Distributed Data Entry. Proceedings of the Twenty-Fith Annual SAS Users Group International Conference, SAS Institute (ed), 1212-1217, 2000.
  69. Perry HM, Miller JP, Baty JD, Carmody SE, Sambhi MP. Pretreatment Blood Pressure as a Predictor of 21-Year Mortality. Am J Hypertension, 13:724-33, 2000.
  70. Schmitt FA, Miller JP, Kryscio RJ. Promoting Interactions with Basic Scientists and Clinicians: Summary of the Panel Session. Statistics in Medicine, 19:1463-8, 2000.
  71. Gordon MO, Kass MA and the Ocular Hypertension Treatment Study (OHTS) Group. The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants. Archives of Ophthalmology, 117:573-83, 1999.
  72. Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyona H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB. A Double-Blind, Placebo-Controlled Study of Mycobacterium-Specific Human Immune Responses Induced by Intradermal Bacille Calmete-Guerin Vaccination. J Lab Clin Med, 134(3):244-52, 1999.
  73. Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwartz SW, Morris MM, Miller JP, Anderson CJ. Radiotherapy and Dosimetry of 64Cu-TETA-Tyr3-Octroetate in a Somatostatin Receptor-Positive Tumor-Bearing Rat Model. Clinical Cancer Research, 5:3608-16, 1999.
  74. Porter FL, Wolf CM, Miller JP. Procedural Pain in Newborn Infants: The Influence of Intensity and Development. Pediatrics, 104:1-10, 1999.
  75. Porter FL, White D, Attaway N, Miller JP, Strunk RC. Absence of diurnal variability of airway reactivity and hypoxic ventilatory drive in adolescents with stable asthma. Journal of Allergy and Clinical Immunology, 103:804-09, 1999.
  76. Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI. Hippocampal Morphometry in Schizophrenia by High Dimensional Brain Mapping. Proc Natl Acad Sci, 95:11406-11, 1998.
  77. Neil JJ, Shiran SI, McKinstry RC, Schefft GL, Snyder AZ, Almi CR, Akbudak E, Aronovitz JA, Miller JP, Lee BCP, Conturo TE. Normal Brain in Human Newborns: Apparent Diffusion Coefficient and Diffusion Anisotropy Measured by Using Diffusion Tensor MR Imaging. Radiology, 209:57-66, 1998.
  78. Miller DK, Morrison MJ, Blair SD, Miller JP, Morley JE. Predilection for Frailty Remedial Strategies Among Black and White Seniors. Southern Medical J, 91:375-380, 1998.
  79. Porter FL, Wolf CM, Miller JP. The Effect of Handling and Immobilization on the Response to Acute Pain in Newborn Infants. Pediatrics, 102:1383-9, 1998.
  80. Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L. A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders. Archives of Neurology, 55:395-401, 1998.
  81. Kennedy RM, Porter FL, Miller JP, Jaffe D. Comparison of Fentanyl/Midazolam with Ketamine/Midazolam for Pediatric Orthopedic Emergencies. Pediatrics, 102:956-63, 1998.
  82. Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders A. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer's Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex and ApoE Genotype. Archives of Neurology, 55:326-35, 1998.
  83. Schechtman KB, Kutner NG, Wallace RB, Buchner DM, Ory MG and the FICSIT Group. Gender, Self-Reported Depressive Symptoms, and Sleep Disturbance Among Older Community-Dwelling Persons. J. Psychosomatic Res, 43:513-27, 1997.
  84. Porter FL, Wolf CM, Gold J, Lotsoff D, Miller JP. Pain and Pain Management in Newborn Infants: A Survey of Physicians and Nurses. Pediatrics, 100:626-32, 1997.
  85. Miller JP. Confounding and Comorbidity in Sarcopenia Research. Muscle & Nerve, Supplement 5:S35-8, 1997.
  86. Miller DK, Carter ME, Sigmund RH, Smith JQ, Miller JP, Bentley JA, McDonald K, Coe RM, Morley JE. Nutritional Risk in Inner-City-Dwelling Older Black Americans. J Am Geriatrics Society, 44:959-62, 1996.
  87. Porter FL, Malhotra KM, Wolf CM, Smith MC, Miller JP, Morris JC. Dementia and Response to Pain in the Elderly. Pain, 68:413-21, 1996.
  88. Rossiter-Fornoff JE, Wolf SL, Wolfson LI, Buchner DM and the FICSIT Group. A Cross-sectional Validation Study of the FICSIT Common Data Base Static Balance Measures. J of Gerontology: Medical Sciences, 50:M291-M297, 1995.
  89. Province M, Miller JP, Tinetti M, Hadley E, Wolf S, Mulrow C, Lipsitz L, Sattin R, Ory M, Hornbrook M. The Effects of Exercise on Falls in the Frail Elderly: A Pre-Planned Meta-Analysis of the FICSIT Trials. J Amer Medical Assoc, 273:1341-7, 1995.
  90. Fix AS, Wozniak DF, Truex LL, McEwen M, Miller JP, Olney JW. Quantitative Analysis of Factors Influencing Neuronal Necrosis Induced by MK-801 in the Rat Posterior Cingulate/Retrosplenial Cortex. Brain Research, 696:194-204, 1995.
  91. Cress ME, Schechtman K, Mulrow C, Gerety M, Fiatarone M, Buchner D, Martin M and the FICSIT Study Group. Relationship between physical performance and Self-Perceived Physical Function. J Am Geriatrics Society, 43:93-101, 1995.
  92. Arfken CL, Lach H, McGee S, Birge SJ, Miller JP. Visual Acuity, Visual Disabilities and Falling in the Elderly. J of Aging & Health, 6:38-50, 1994.
  93. Perry HM, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE. Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients. Hypertension, 25:587-94, 1995.
  94. Gates GA, Karzon RK, Garcia P, Peterein J, Storandt M, Morris JC, Miller JP. Auditory Dysfunction in Aging and Senile Dementia of the Alzheimer's Type. Archives of Neurology, 52:626-34, 1995.
  95. Miller JP, Perry HM, Rossiter JE, Baty JD, Carmody SE, Sambhi MP. Regional Differences in Mortality During 15 Year Follow-up of 11,936 Hypertensive Veterans. Hypertension, 23:431-8, 1994.
  96. Arfken CL, Lach HW, Birge SJ, Miller JP. The Prevalence and Correlates of Fear of Falling in Community-Dwelling Elderly Persons. Am J Pub Health,84: 565-570, 1994.
  97. Kutner N, Schechtman K, Ory M, Baker D and the FICSIT Group. Older Adults' Perceptions of their Health and Functioning in Relation to Sleep Disturbance, Falling and Urinary Incontinence. J Am Geriatrics Society, 42: 757-62, 1994.
  98. Arens M, Joseph T, Nag S, Miller JP, Powderly WG, Ratner L. Alterations in Spliced and Unspliced HIV-1-Specific RNA Detection in Peripheral Blood Mononuclear Cells of Individuals with Varying CD4-Positive Lymphocyte Counts. AIDS Research and Human Retroviruses, 9:1257-63, 1993.
  99. Ory M, Schechtman K, Miller JP, Hadley E, Fiatarone M, Province M, Arfken C, Morgan D, Weiss S and the FICSIT Group. Frailty and Injuries in Later Life: the FICSIT Trials. J Am Geriatrics Society, 41:283-96, 1993.
  100. Buchner DM, Hornbrook MC, Kutner NG, Tinetti ME, Ory MG, Mulrow CD, Schechtman KB, Gerety MB, Fiatarone MA, Wolf SL, Rossiter J, Arfken C, Kanten K, Lipsitz LA, Sattin RW, DeNino LA, and the FICSIT Group. Development of the Common DataBase for the FICSIT Trials. J Am Geriatrics Society, 41:297-308, 1993.
  101. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J, King W, Signore L, Schierbecker J, Florence J, Matheson-Burden N, Wilson B. Duchenne Dystrophy: Randomized, Controlled Trial of Prednisone (18 Months) and Azathioprine (12 Months). Neurology, 43:520-7, 1993.
  102. Ory MG, Schechtman KB, Miller JP, Hadley EC, Fiatarone MA, Province MA, Arfken CL, Morgan D, Weiss S, Kaplan M, and the FICSIT Group. Frailty and Injuries in Later Life: The FICSIT Trials. J Am Geriatrics Society, 41:283-96, 1993.
  103. McKeel DW, Ball MJ, Price JL, Smith DS, Miller JP, Berg L, Morris JC. Interlaboratory Histopathologic Assessment of Alzheimer Neuropathology: Different Methodologies Yield Comparable Diagnostic Results. Alzheimer Disease and Associated Disorders, 7:136-151, 1993.
  104. Berg L, McKeel DW, Jr., Miller JP, Baty J. Neuropathologic Indexes of Alzheimer's Disease in Demented and Nondemented People Aged Eighty Years and Over. Archives of Neurology, 50:349-58, 1993.
  105. Rubin EH, Storandt M, Miller JP, Grant EA, Kinscherf DA, Morris JC, Berg L. Influence of Age on Clinical and Psychometric Assessment of Subjects with Very Mild or Mild Dementia of the Alzheimer Type. Archives of Neurology, 50:380-3, 1993.
  106. Cumming RG, Miller JP, Birge SJ, Davis P. Medications, Fallers and Non-fallers (author response to Letter to the Editor). Age & Aging, 21:226-7, 1992.
  107. Buller RS, Bailey TC, Ettinger NA, Keener M, Langlois T, Miller JP, Storch GA. Use of a Modified Shell Vial Technique to Quantitate Cytomegalovirus Viremia in a Population of Solid-Organ Transplant Recipients. J Clin Microbiology, 30:2620-4, 1992.
  108. Perry HM, Miller JP. Difficulties in Diagnosing Hypertension: Implications and Solutions. J Hypertension, 10:887-96, 1992.
  109. Erdman HP, Klein MH, Greist JH, Skate SS, Husted JJ, Robins LN, Helzer JE, Goldring E, Hamburger M, Miller JP. A Comparison of Two Computer-Administered Versions of the NIMH Diagnostic Interview Schedule. J Psych Research, 26:85-95, 1992.
  110. Florence J, Pandya S, King W, Robison J, Baty J, Miller JP, Schierbecker J, Signore L. Intrarater Reliability of the Manual Muscle Test (Medical Research Council Scale) in Duchenne's Muscular Dystrophy. Physical Therapy, 72: 115-22 124-6 (author response), 1992.
  111. Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G. Mild Senile Dementia of the Alzheimer Type: 4. Evaluation of Intervention. Annals of Neurology, 31:242-9, 1992.
  112. Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ, Miller JP, Abrams JC, Goldstein R, Moss AJ, and the Multicenter Diltiazem Post-Infarction Trial Research Group. Electrocardiographic Subset Analysis of Diltiazem Administration on Long-Term Outcome after Acute Myocardial Infarction. Am J Cardiology, 67:335-42, 1991.
  113. Wozniak DF, Stewart GR, Miller JP, Olney JW. Age-Related Sensitivity to Kainate Neurotoxicity. Experimental Neurology, 114:250-3, 1991.
  114. Fenichel GM, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, Pandya S, Florence J, Schierbecker J, Wilson B. A Comparison of Daily and Alternate-Day Prednisone Therapy in the Treatment of Duchenne Muscular Dystrophy. Archives of Neurology, 48:575-9, 1991.
  115. Fenichel GM, Florence MJ, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W, Signore L, Pandya S, Schierbecker J, Wilson B. Long-Term Benefit from Prednisone Therapy in Duchenne Muscular Dystrophy. Neurology, 41:1847-77, 1991.
  116. Cumming RG, Miller JP, Kelsey JL, Davis P, Arfken CL, Birge SJ, Peck WA. Medications and Multiple Falls in the Elderly: The St. Louis OASIS Study. Age & Aging, 20:455-61, 1991.
  117. Perry HM, Masironi R, Parr R, Miller JP. Concentration of Trace Metals (Cd, Zn, Se, Cu, Cr, and Fe) in Organs (Heart, Kidney, and Liver) of Subjects with Myocardial Infarction or Hypertension: WHO/IAEA Myocardial Infarction and Hypertension Autopsy Study. J Trace Elements in Experimental Medicine, 4:109-28, 1991.
  118. Kahn MG, Abrams CA, Orland MJ, Beard JC, Cousins SB, Miller JP, Santiago JV. Intelligent Computer-based Interpretation and Graphical Presentation of Self-monitored Blood Glucose and Insulin Data. Diabetes, Nutrition and Metabolism, 4:99-107, 1991.
  119. Burke WJ, O'Malley KL, Chung HD, Harmon SK, Miller JP, Berg L. Effect of Pre- and Postmortem Variables on Specific mRNA Levels in Human Brain. Molecular Brain Research, 11:37-41, 1991.
  120. Porter FL, Miller JP, Marshall RE, Cole FS. A Controlled Clinical Trial of Local Anesthesia for Lumbar Punctures in Newborn Infants. Pediatrics, 88:663-9, 1991.
  121. Lach HW, Arfken CL, Reed AT, Miller JP, Birge SJ, Peck WA. Falls in the Elderly: Reliability of a Classification System. J Am Geriatrics Society, 39:197-202, 1991.
  122. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP and the CIDD Group. Prednisone in Duchenne Dystrophy: A Randomized, Controlled Trial Defining the Time Course and Dose Response. Archives of Neurology, 48:383-88, 1991.
  123. Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AHM, Mendell JR, CIDD Study Group. Dystrophin Expression and Somatic Reversion in Prednisone-Treated and Untreated Duchenne Dystrophy. Neurology, 41:661-6, 1991.
  124. Kissel JT, Burrow KL, Rammohan KW, Mendell JR, CIDD Study Group. Mononuclear Cell Analysis of Muscle Biopsies in Prednisone-Treated and Untreated Duchenne Muscular Dystrophy. Neurology, 41:667-72, 1991.
  125. Clifford DB, Jacoby RG, Miller JP, Seyfried WR, Glicksman M. Neuropsychometric Performance of Asymptomatic Human Immunodeficiency Virus Patients. AIDS, 4:767-74, 1990.
  126. Wozniak DF, Olney JW, Kettinger L, III, Price M, Miller JP. Behavioral effects of MK-801 administration in the Rat. Psych Pharm, 101:47-56, 1990.
  127. Miller, JP. Statistical Considerations in Clinical Trials. Muscle & Nerve, 13:S43-4, 1990.
  128. Kleiger RE, Miller JP, Krone RJ, Bigger JT, the Multi-Center Post-Infarction Research Group. The Independence of Cycle Length Variability and Exercise Testing on Predicting Mortality of Patients Surviving Myocardial Infarction. Am J Cardiology, 65:408-11, 1990.
  129. Berg L, Smith DS, Morris JC, Miller JP, Rubin EH, Storandt M, Coben LA. Mild Senile Dementia of the Alzheimer Type: 3. Longitudinal and Cross-Sectional Assessment. Annals of Neurology, 28:648-52, 1990.
  130. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing Family Sharing of Diabetes Responsibilities. J Ped Psych, 15:477-92, 1990.
  131. Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LM, Therneau TM. Nonfatal Myocardial Infarction Is, by Itself, an Inappropriate Endpoint in Clinical Trials in Cardiology. Circulation, 81:684-5, 1990.
  132. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Mandel S, Florence J, Schierbecker J, Kaiser KK, King W, Pandya S, Robison J, Signore L. Randomized, Double-Blind Trial of Mazindol in Duchenne Dystrophy. Muscle & Nerve, 13:1169-73, 1990.
  133. Miller JP. The SAS System on the UNIX Operating Systems and Derivatives: The Missing Link. Proceedings of the 1989 SAS User's Group International, 1623-7, 1989.
  134. Mendell JR, Moxley RT, Griggs, RC, Brooke MW, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, Schierbecker J, Robison J, Kaiser K, Mandel S, Arfken C, Gilder B. Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy. New England J Medicine, 320:1592-7, 1989.
  135. Miller JP. Statistical Considerations for Quantitative Techniques in Clinical Neurology. In:Quantification of Neurologic Deficit, Theodore Munsat, (ed), Butterworths, Stoneham MA, 69-84, 1989.
  136. Brooke MH, Fenichel GM, Griggs, RC, Mendell JR, Moxley R, Miller JP, Gilder BF, Florence J, Kaiser KK, King WM, Pandya S, Robison J, Signore L, Mandel S, Arfken C. Duchenne Muscular Dystrophy: Patterns of Clinical Progression and Effects of Supportive Therapy. Neurology, 39:475-81, 1989.
  137. Krone RJ, Dwyer EM, Greenberg H, Miller JP, Gillespie JA, the Multicenter Post-Infarction Research Group. Risk Stratification in Patients with First Non-Q-Wave Infarction, Limited Value of the Early Low Level Exercise Test after Uncomplicated Infarcts. J Am College of Cardiology, 14:31-7, 1989.
  138. Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr B, Moxley R. Randomized Controlled Trial of Testosterone in Myotonic Dystrophy. Neurology, 39:219-22, 1989.
  139. The Multicenter Diltiazem Postinfarction Trial Research Group. The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction. New England J Medicine, 319:385-92, 1988.
  140. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT, Park JH, Province MA, Florence J, Kaiser KK, King WM, Pandya S, Robison JD, Signore L. Clinical Investigation in Duchenne Muscular Dystrophy: VII. Double Blind Controlled Trial of Penicillamine and Vitamin E. Muscle & Nerve, 11:1164-8, 1988
  141. Bigger JT, Jr., Kleiger RE, Fleiss JL, Rolnitzky LM, Steinman RC, Miller JP, Multicenter Post-Infarction Research Group. Components of Heart Rate Variability Measured During Healing of Acute Myocardial Infarction. Am J Cardiology, 61:208-15, 1988.
  142. Faber-Langendoen K, Morris J, Knesevich J, LaBarge E, Miller JP, Berg L. Aphasia in Senile Dementia of the Alzheimer Type. Ann Neurology , 23:365-70, 1988.
  143. Krone RJ, Gillespie JA, Weld FM, Miller JP. Low-Level Exercise Testing in Patients taking Beta Blocking Agents. Card Board Rev, 5:165-76, 1988.
  144. Berg L, Miller JP, Storandt M, Duchek J, Morris J, Rubin E, Burke W, Coben L. Mild Senile Dementia of the Alzheimer Type: 2, Longitudinal Assessment. Ann Neurology, 23:477-84, 1988.
  145. Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J, Wittels IG, Berg L. Reliability of the Washington University Clinical Dementia Rating. Arch Neurology, 45:31-2, 1988.
  146. Mandel SA, Miller JP. A Data Base Interrogation System with the SAS System for Personal Computers. Proceedings of the 13th Annual SUGI Conference, SAS Institute, Cary NC, 681-5, 1988.
  147. Hyser CL, Province MA, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Polakowaska R, Doherty RA, Quirk S, CIDD Group. Genetic Heterogeneity in Duchenne Dystrophy. Ann Neurology, 22:553-5, 1987.
  148. Miller JP, Parks RP. What Good is the SAS System for Personal Computers? Proceedings of the 12th Ann SUGI Conference, SAS Institute, Cary NC, 827-34, 1987.
  149. Krone RJ, Miller JP, Gillespie JA, Weld FM, Multicenter Post-Infarction Research Group. Usefulness of Low Level Exercise Testing Early After Acute Myocardial Infarction in Patients Taking Beta Blocking Agents. Am J Cardiology, 60:23-7, 1987.
  150. Mendell JR, Province MA, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, Kaiser KK, King W, Robison J, Signore L, Pandya S, Florence JM, Seyfried W, Mandel S. Clinical Investigation of Duchenne Muscular Dystrophy: A Methodology for Therapeutic Trials Based on Natural History Controls. Arch Neurology, 44:808-12, 1987.
  151. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L, King W, Robison J, Head RA, Province M, Seyfried W, Mandel S. Clinical Investigation of Duchenne Dystrophy: Interesting Results in a Trial of Prednisone. Arch Neurology, 44:812-7, 1987.
  152. Kleiger RE, Miller JP, Bigger JT, Jr., Moss AJ. Multicenter Post-Infarction Research Group. Decreased Heart Rate Variability and Its Association with Increased Mortality After Acute Myocardial Infarction. Am J Cardiology, 59:256-62, 1987.
  153. Wetzel RD, Reich T, Murphy GE, Province MA, Miller JP. The Changing Relationship Between Age and Suicide Rates: Cohort Effect, Period Effect or Both? Psychiatric Developments, 3:179-218, 1987.
  154. Moxley RT, III, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: VI. Double-Blind Controlled Trial of Nifedipine. Muscle & Nerve, 10:22-33, 1987.
  155. Madsen KS, Miller JP, Province MA, the CIDD Group. The Use of an Extended Baseline Period in the Evaluation of Treatment in a Longitudinal Duchenne Muscular Dystrophy Trial. Statistics in Medicine, 5:231-41, 1986.
  156. Rogers DG, White NH, Santiago JV, Miller JP, Weldon VV, Kilo C, Williamson JR. Glycemic Control and Bone Age are Independently Associated with Muscle Capillary Basement Membrane Width in Diabetic Children After Puberty. Diabetes Care, 9:453-9, 1986.
  157. Brooke MH, Florence JM, Heller SL, Kaiser KK, Phillips D, Gruber A, Babcock D, Miller JP. Controlled Trial of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis. Neurology, 36:146-51, 1986.
  158. Doherty RA, Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Conneally PM. Use of Genetic-Linkage Combined with Serum Creatine-Kinase and Pyruvate-Kinase for Carrier Detection in Duchenne Dystrophy. Pediatric Res, 19:4, 1985.
  159. Storch GA, Perrillo RP, Miller JP, Benz B, Kahn RH. Prevalence of Hepatitis B Antibodies in Personnel at a Children's Hospital. Pediatrics, 76:29-35, 1985.
  160. Gonen B, White N, Schonfeld G, Skor D, Miller JP, Santiago J. Plasma Levels of Apoprotein B in Patients with Diabetes Mellitus: The Effect of Glycemic Control. Metabolism, 34:675-9, 1985.
  161. Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province MA, Moxley RT, III, Huntzinger D, Vaughn A, Cohen M, Conneally PM, Bach P, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: V. Use of Creatine Kinase and Pyruvate Kinase in Carrier Detection. Muscle & Nerve, 8:60-7, 1985.
  162. Krone RJ, Gillespie JA, Weld FM, Miller JP, Moss AJ, Multicenter Postinfarction Research Group. Low-Level Exercise Testing after Myocardial Infarction: Usefulness in Enhancing Clinical Risk Stratification. Circulation, 71:80-9, 1985.
  163. Miller JP. Use of Diagnostic Registries and DataBases. Muscle & Nerve, MDA Colloquium, 1985.
  164. Mendell JR, Griggs RC, Moxley RT, Fenichel GM, Brooke MH, Miller JP, Province MS, Dodson WE, the CIDD Group. Clinical Investigation in Duchenne Muscular Dystrophy: IV. Double-Blind Controlled Trial of Leucine. Muscle & Nerve, 7:535-41, 1984.
  165. Bigger JT, Fleiss JL, Kleiger RE, Miller JP, Rolnitzky LM, Multicenter Postinfarction Research Group. The Relationships Among Ventricular Arrhythmias, Left Ventricular Dysfunction, and Mortality in the 2 Years After Myocardial Infarction. Circulation, 69:250-8, 1984.
  166. Krone RJ, Miller JP, Province MA, Kleiger RE, Thanavaro S, Oliver GC. Primary Cardiology, 10:8-22, 1984.
  167. Brooke MH, the CIDD Group. Therapeutic Trials in Duchenne Muscular Dystrophy. The Scientific Difference Between "Didn´t" and "Doesn't". Ital J Neurol Sci, Suppl 3:127-31, 1984.
  168. Hopper S, Miller JP, Birge C, Swift J. A Randomized Study of the Impact of Home Health Aides on Diabetic Control and Utilization Patterns. Am J Pub Health, 74:600-2, 1984.
  169. Thomas LJ, Miller JP. Long-Term Ambulatory ECG Recording in the Determination of Antidysrhythmic Drug Efficacy. In: Clinical Pharmacology of Antiarrhythmic Therapy, BR Lucchesi, JV Dingell, RP Schwarz, Jr. (eds), Raven Press, New York, 1984.
  170. Florence JM, Pandya S, King WM, Robison J, Signore L, Wentzell M, Province M, CIDD Group. Clinical Investigation in Duchenne Dystrophy: 3. Standardization and Reliability of Evaluation Procedures. Physical Therapy, 64:41-5, 1984.
  171. Rosen SG, Clutter WE, Shah SD, Miller JP, Bier DM, Cryer PE. Direct Alpha-adrenergic Stimulation of Hepatic Glucose Production in Postabsorptive Man. Am J Psych, 245:616-26, 1983.
  172. The Multicenter Postinfarction Research Group. Risk Stratification and Survival after Myocardial Infarction. New England J Medicine, 309:331-6, 1983.
  173. Miller JP. Letter to the Editor Re: Adverse Reactions to Contrast Material. Radiology, 149:325, 1983.
  174. Tse TF, Clutter WE, Shah SD, Miller JP, Cryer PE. Neuroendocrine Responses to Glucose Ingestion in Man: Specificity, Temporal Relationships and Quantitative Aspects. J Clin Invest, 72:270-77, 1983.
  175. Thanavaro S, Kleiger RE, Miller JP, Province MA, Friedman E, Oliver GC. Coupling Interval and Types of Ventricular Ectopic Activity Association with Ventricular Runs. Am Heart J, 106:484-91, 1983.
  176. Lewis CE, Croughan JL, Whitman BY, Miller JP. The Association of Alcoholism and Antisocial Personality in a Narcotic Dependent Population: The Lexington Addicts. Psy Res, 10:31-46, 1983.
  177. Krone RJ, Friedman E, Thanavaro S, Miller JP, Kleiger RE, Oliver GC. Long-term Prognosis of Patients with First Q-Wave (Transmural) or Non-Q-Wave (Nontransmural) Myocardial Infarction: Analysis of 593 Patients. Am J Cardiology, 52:234-9, 1983.
  178. Ganda OP, Williamson JR, Soeldner JS, Gleason RE, Kilo C, Kaldany A, Miller JP, Garovoy MR, Carpenter CB. Muscle Capillary Basement Membrane Width and Its Relationship to Diabetes Mellitus in Monozygotic Twins. Diabetes, 32:549-56, 1983.
  179. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA, the CIDD Group. Clinical Investigation in Duchenne Dystrophy: II. Determination of the "Power" of Therapeutic Trials Based on the Natural History. Muscle & Nerve, 6:91-103, 1983.
  180. Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Rowold E, Hoffman P, Faller A, Kilo C, Miller JP, Williamson JR. Muscle Capillary Basement Membrane in Identical Twins Discordant for Insulin-Dependent Diabetes. Diabetes, 32:557-60, 1983.
  181. Bach PR, the CIDD Group. Determination of Nifedipine in Serum or Plasma by Reversed-Phase Liquid Chromatography. Clin Chem, 29:1344-8, 1983.
  182. Whitman BY, Croughan JL, Miller JP, McKay J. Nonpsychiatric Predictors of Narcotic Dependence: A Prospective Study with a 5-Year Followup. Int J Addiction, 17:473-91, 1982.
  183. Thanavaro S, Kleiger RE, Province MA, Hubert J, Miller JP, Krone RJ, Oliver GC. Effect of Infarct Location on the In-Hospital Prognosis of Patients with First Transmural Myocardial Infarction. Circulation, 66:742-7, 1982.
  184. Clark KW, Geltman EM, Miller JP, Madden KA, Thomas LT, Jr., Jaffe AS, Gold HK, Raabe DS, Stone PH, Rude RE, Hartwell TD, MILIS Cooperating Investigators. Reproducibility of Dysrhythmia Findings by a Centralized Laboratory within a Major Multicenter Trial. Proceedings of the 1982 Computers in Cardiology, 55-60, 1982.
  185. Croughan JL, Miller JP, Whitman BY, Lavazzi CM. Methods for Recording Lifetime History of Substance Abuse. Int J Addiction , 17:1065-78, 1982.
  186. Croughan JL, Miller JP, Wangelin D, Whitman BY. Psychiatric Illness in Male and Female Narcotic Addicts. J Clin Psychiatry, 43:223-8, 1982.
  187. Province MA, Miller JP, Wette R. PROC TETCORR: Correlations Between Categorical and Continuous Variables. Proceedings of the 7th Annual SUGI Conference, 672-5, 1982.
  188. Province MA, McCrate MM, Miller JP. PROC COMPARE and HEADER for Efficient Database Management in SAS. Proceedings of the 7th Annual SUGI Conference, 857-9, 1982.
  189. Croughan JL, Miller JP, Matar A, Whitman BY. Psychiatric Diagnosis and Prediction of Drug and Alcohol Dependence. J Clin Psychiatry, 43:353-6, 1982.
  190. Miller JP, Wette R. Type I Error Rates for the Behrens-Fisher Problem. Proceedings of the 1981 Statistical Computing Section of ASA, 160-4, 1981.
  191. Anderson B, Miller JP, Auslander W, Santiago J. Family Characteristics of Diabetic Adolescents. Diabetic Care, 4:586-94, 1981.
  192. Krone RJ, Miller JP, Kleiger RE, Clark KW, Oliver GC. The Effectiveness of Antiarrhythmic Agents on Early Cycle PVCs. Circulation, 63:664-9, 1981.
  193. Croughan JL, Miller JP, Whitman BY, Schober JG. Alcoholism and Alcohol Dependence in Narcotic Addicts - A Prospective Study with a 5-Year Followup. J Drug & Alcohol Abuse, 8:85-94, 1981.
  194. Croughan JL, Miller JP, Koepke J, Whitman BY. Depression in Narcotic Addicts - A Prospective Study with a Five-Year Follow-Up. Comprehensive Psychiatry, 22:428-33, 1981.
  195. Kleiger RE, Miller JP, Thanavaro S, Province MA, Martin TF, Oliver GC. Relationship between Clinical Features of Acute Myocardial Infarction and Ventricular Runs 2 Weeks to 1 Year After Infarction. Cardiology World, 7:6, 1981.
  196. Miller JP, Wette R, Parks RP. Type I Error Rates for the Unequal Variance T Test. Proceedings of the 6th Annual SUGI Conference, SAS Institute, Raleigh, NC, 156-61, 1981.
  197. Rice JP, Miller JP, Cloninger CR. Path Analytic Models in Human Quantitative Genetics. Proceedings of the 6th Annual SUGI Conference, SAS Institute, Raleigh, NC, 110-5, 1981.
  198. Kleiger RE, Miller JP, Thanavaro S, Province MA, Martin TF, Oliver GC. Relationship Between Clinical Features of Acute Myocardial Infarction and Ventricular Runs 2 Weeks to 1 Year after Infarction. Circulation, 63:64-70, 1981.
  199. Krone JR, Igielnik S, Miller JP. A Computerized Report Generating/Data Management System for a Cardiology Division. Proceedings of the 4th Annual WAMI Meeting, FB Begon (ed), Strasbourg, France, 277-82, 1981.
  200. Clark KW, Rolnitzky LM, Miller JP, DeCamilla JJ, Kleiger RE, Thanavaro S, Bigger JT, Jr, and other MPIP Participants. Ambulatory ECG Analysis Shared by Two Independent Computer Labs in the Multicenter Post-Infarction Program (MPIP). Proceedings of the 1980 Computers in Cardiology, IEEE 80CH1606-3, 271-4, 1981.
  201. Kass, MA, Hart WM, Gordon M, Miller JP. Risk Factors Favoring the Development of Glaucomatous Visual Field Loss in Ocular Hypertension. Survey Ophth, 25:155-62, 1980.
  202. Kilo C, Miller JP, Williamson JR. The Crux of the UGDP. Spurious Results and Biologically Inappropriate Data Analysis. Diabetologia, 18:179-85, 1980.
  203. Brandenberger LL, Oliver GC, Miller JP, Thomas LJ, Jr, Moore P. Development of a Computer-Assisted Follow-up Method for Clinical Research. Proceedings of the 4th Annual Symposium on Computer Applications in Medical Care, IEEE 80CH1570-1, 1037-43, 1980.
  204. Kilo C, Miller JP, Williamson J. The Achilles Heel of the University Group Diabetes Program. J Am Medical Assn, 243:450-7, 1980.
  205. Thanavaro S, Krone RJ, Kleiger RE, Province MA, Miller JP, deMello V, Oliver GC. In-Hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions. Circulation, 61:29-33, 1980.
  206. Martin TF, Kleiger RE, Miller JP, deMello V, Oliver GC. Longterm Stability of Ventricular Arrhythmias After Recovery from Infarction. In:Progress in Cardio-Pulmonary Diseases, MP Anand, SJ Shah, (eds), States People Press, Bombay, India, 80-93, 1979.
  207. Kilo C, Williamson JR, Choi SC, Miller JP. Refuting the UGDP Conclusion that Insulin Treatment Does Not Prevent Vascular Complications in Diabetes. In:Treatment of Early Diabetes: Advances in Experimental Medicine in Biology, RA Camerini-Davalos, B Hanover, (eds), 119:307-11, Plenum Press, NY, 1979.
  208. Cloninger CR, Miller JP, Wette R, Martin RL, Guze SB. The Evaluation of Diagnostic Concordance in Follow-up Studies: I. A General Model of Casual Analysis and a Methodological Critique. J Psych Reseach15:85-106, 1979.
  209. Insulin Treatment and Diabetic Vascular Complications. (Letter) J Am Medical Assn241:26, 1979.
  210. Krone RJ, Igielnik S, Miller JP. A Computerized Cardiology Report Generating/Data Management System. Proceedings of the 1979 Computers in Cardiology, IEEE 79-CH1462-1, 469-72, 1979.
  211. Thanavaro S, Krone RJ, Kleiger RE, Province MA, Miller JP, deMello VR, Oliver GC. In-Hospital Prognosis of Patients with First Nontransmural and Transmural Infarctions. Int Congress Series No. 491: Florence International Meeting on Myocardial Infarction, Excerpta Medica, Princeton, 99-102, 1979.
  212. Miller JP. The Role of SAS in the Support of Clinical Studies in Medicine.Proceedings of the 4th Annual Conference of SUGI, SAS Inst. Raleigh, NC, 300-5, 1979.
  213. Hruska KA, Teitelbaum SL, Kopelman R, Richardson CA, Miller JP, Debman J, Martin K, Slatopolsky E. The Predictability of the Histological Features of Uremic Bone Disease by Noninvasive Techniques. Metab Bone Dis & Related Research, 1:39-44, 1978.
  214. Moore P, Miller JP, Oliver GC, Thomas LJ, Jr. Task-Oriented Management Information Systems for Clinical Studies.Proceedings of 1978 Computers in Cardiology, IEEE 78-CH-1391-2C, 149-54, 1978.
  215. Miller JP, Spitznagel E, Jr., Kass M. The Use of Loglinear and Multivariate Logistic Models to Assess the Association Between HLA Antigen Responses and Disease. Proceedings of the Statistical Computing Section, Am Stat Assoc, 271-5, 1978.
  216. Miller JP, McCrate MM, Province MA, Wette R. Maximum Likelihood Estimation of the Multivariate Logistic. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Inst, Raleigh, NC, 303-5, 1978.
  217. Powell D, Miller JP, Cloninger CR. The Use of SAS for the Analysis of Family Studies. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Institute, Raleigh, NC, 189-94, 1978.
  218. Achtenberg J, Miller JP. Interfacing a MUMPS-Based Data Entry System to SAS. Proceedings of the 3rd Annual Conference of SUGI, RH Strand (ed), SAS Institute, Raleigh, NC, 161-7, 1978.
  219. Kass MA, Palmberg PK, Becker B, Miller JP. Histocompatibility Antigens and Primary Open-Angle Glaucoma - A Reassessment. Arch Ophthamology, 96:2207-8, 1978.
  220. Burslem J, Schonfeld G, Howald MA, Weidman SW, Miller JP. Plasma Apoprotein and Lipoprotein Lipid Levels in Vegetarians. Metabolism, 27:711-9, 1978.
  221. Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD, Jr. Chronic Progressive Renal Disease: Rate of Change of Serum Creatine Concentration. Kidney Inter, II:62-70, 1977.
  222. Miller JP. A Parsimonious Approach to Data Transformations. Proceedings of the 1977 Statistical Computing Section, Am Stat Assoc, 327-31, 1977.
  223. Miller JP.Discussion for Invited Session on Research Data Management.Proceedings of the 1977 Statistical Computing Section, Am Stat Assoc, 73-5, 1977.
  224. Oliver GC, Ripley KL, Miller JP, Martin TF. A Critical Review of Computer Arrhythmia Detection. In: Computer Electrocardiography: Present Status and Criteria, L Pordy (ed) 319-60, Futura Press, 1977.
  225. Miller JP, Moore P, Achtenberg J, Thomas LJ, Jr. Computerized Information Handling for Long-Term Clinical Studies. Proceedings of the 1977 Computers in Cardiology, IEEE Catalog 77-CH-1243-2C, 151-9, 1977.
  226. Clark KW, Moore P, Miller JP, Thomas LJ, Jr. A Total Systems Approach to the Quantitative Analysis of Holter-Recorded ECGs. Proc Int Symposium on Ambulatory Monitoring, Academic Press, 59-71, 1977.
  227. Miller JP. A Parsimonious Approach to Data Transformations. Proceedings of the 2nd Annual SUGI, K Offord (ed), 74-8, SAS Institute, Raleigh, NC, 1977.
  228. Achtenberg JA, Miller JP, Cryer P, Santiago J. Data 3 - A Forms Management System. Proc 1976 MUMPS Users Group, J Rothmeier, (ed), 1-8, MUMPS Users' Group, St, Louis, 1976.
  229. Moore P, Miller JP, Moran M, Clark KW, Oliver GC. A Management Information System Designed to Oversee a Clinical Study.Proceedings of 1976 MUMPS Users Group, J Rothmier (ed), 85-96, MUMPS Users Group, St. Louis, 1976.
  230. Miller JP, Ritter JA, Clark KW, Thomas LJ, Jr, Oliver GC. Extended Analysis of Argus/H Quantified Ventricular Ectopic Activity. Proceedings of Computers in Cardiology, IEEE Cat No 76-CH-1160-1C, 165-70, 1976.
  231. Miller JP. The Relationship of SAS to Other Packages. Proceedings of the 1976 SAS Users Group, J Horwitch (ed) SAS Institute, Raleigh NC, 380-7, 1976.
  232. Hillman L, Schonfeld G, Miller JP, Wulff G. Apolipoproteins in Human Pregnancy. Metabolism, 24:943-52, 1975.
  233. Kleiger RE, Martin TF, Miller JP, Oliver GC. Mortality of Myocardial Infarction Treated in the CCU. Heart & Lung, 4:215-26, 1975.
  234. Achtenberg J, Miller JP. Diabetes Center Patient Registry. Proc 1975 MUMPS Users Group, J Zimmerman (ed), MUMPS Users' Group, St. Louis, 1-7, 1975.
  235. Oliver GC, Miller JP, Martin TF. A Critical Review of Computer ECG Monitoring: Present Confusion and Future Promise. In:Computer Electrocardiography and Vectocardiography: Current Status, Futura Press, 1974.
  236. Schonfeld G, Birge C, Miller JP, Kessler G, Santiago J. Apolipoprotein B Levels and Altered Lipoprotein Composition in Diabetes. Diabetes, 23:827-34, 1974.
  237. Oliver GC, Kleiger RE, Krone RJ, Martin TF, Miller JP, Nolle FM, Cox JR, Jr. Application of the High Speed Analysis of Ambulatory Electrocardiograms.Proceedings of Computers in Cardiology, 43-6, 1974.
  238. Miller JP, Arp DJ, Psathas G. An Introduction to the Inquirer II System of Content Analysis.Comp Studies in Humanities & Verbal Behavior, III:40-5, 1970.
  239. Miller JP, Bohn SE, Gilden JP, Stevens E. Anxiety as a Function of Taking the MMPI. J Consult & Clin Psych, 32:120-4, 1968.
  240. Miller JP, Psathas G. A 1401-1311 General Inquirer Tagging Program. Behavioral Science, 13:167-9, 1968.

Paul Thompson

  1. O'Neill WC, Robbin ML, Bae KT, Grantham JJ, Chapman AB, Guay-Woodford LM, Torres VE, King BF, Wetzel LH, Thompson PA, Miller JP. Sonographic Assessment of the Severity and Progression of Autosomal-Dominant Polycystic Kidney Disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). American Journal of Kidney Disease, in press.
  2. Bae K, Zhu F, Chapman A, Torres V, Grantham J, Guay-Woodford L, Baumgarten D, King BF, Wetzel LH, Kenney P, Brummer M, Bennett W, Klahr S, Meyers C, Zhang X, Thompson P, Miller J. Magnetic Resonance Imaging (MRI) Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Clinical Journal of American Society of Nephrology, in press.
  3. Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP, for the CRISP Consortium. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. J Amer Society Nephrology, 17(3): 2006 (published online ahead of print: http://jasn.asnjournals.org/cgi/rapidpdf/ASN.2005070697v1.pdf).
  4. Wolf SW, Thompson PA, Taub E, Uswatte G, Miller JP, and the EXCITE Group. The EXCITE trial: Baseline attributes of the Wolf Motor Function Test in Patients with sub-acute stroke. Neurorehabilitation and Neural Repair, 19(3):194-205, 2005.
  5. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grangham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic Resonance Measurements of Renal Blood Flow as a Marker of Disease Severity in Autosomal Dominant Polycystic Kidney Disease. Kidney International, 64:2214-2221, 2003.
  6. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O?Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP. Renal Structure in Early Autosomal-Dominant Polycystic Kidney Disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney International, 64:1035-1045, 2003.
  7. Thompson PA, Littlewood S, Adelman AJ, Miller JP. The Web Data Entry System: Methods for Web Development and SAS Data Management. Proceedings of the SAS Users Group International, April, 2002.
  8. Trinkaus KM, Thompson PA, Miller JP. Using SAS/IntrNet Software to Support Distributed Data Entry. Proceedings of the Twenty-Fith Annual SAS Users Group International Conference, SAS Institute (ed), 1212-1217, 2000.

Kim Trinkaus

  1. Smith SR, Jaffe DM, Fisher EB, Trinkaus KM, Highstein G, Strunk RC. Improving follow-up for children with asthma after an acute Emergency Department visit. Journal of Pediatrics, 2004;145(6):772-777.
  2. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. Journal of Clinical Oncology, 2004;22(16): 3248-3254.
  3. Huang J, Trinkaus K, Huddleston CB, Mendeloff EN, Spray TL, Canter CE. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. Journal of Heart and Lung Transplantation, 2004;23(6): 716-722.
  4. Tsirka AE, Trinkaus KM, Chen SC, Lipschultz SE, Towbin JA, Colan SD, Exil V, Strauss AW, Canter CE. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. Journal of the American College of Cardiology, 2004;44(2): 391-397.
  5. Tezel G, Trinkaus K, Wax MB. Alterations in the morphology of lamina cribrosa pores in glaucomatous eyes. British Journal of Ophthalmology, 2004;88(2): 251-156.
  6. Miller JP, Schauer J, Littlewood S, Trinkaus K, Lill RM, Richard R. Managing Clinical Trials Data with a SAS-based Web Portal. Proceedings of the 28th Annual Meeting of SAS Users Group International (SUGI), 2003, pp.1212-1217. SAS Institute, Cary, NC.
  7. Avasarala JR, Cross AH, Trinkaus KM. Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis. Multiple Sclerosis, 2003;9(3):307-310.
  8. Fuller CE, Schmidt RE, Roth KA, Burger PC, Schneithauer BW, Banerjee R, Trinkaus KM, Lytle R, Perry A. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/ astrocytic features. Journal of Neuropathology and Experimental Neurology, 2003;62(11): 1118-1128.
  9. Bloomberg GR, Trinkaus KM, Fisher EB, Musick JR, Strunk RC. Hospital Readmissions for Childhood Asthma: A 10-Year Metropolitan Study. American Journal of Respiratory and Critical Care Medicine, 2003;167(8):1068-1076.
  10. Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC. Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report. Oncology (Huntingt), 2003;17(( Suppl 8): 27-31.
  11. Custer PL, Lind A, Trinkaus KM. Complications of supramid orbital implants. Ophthalmic Plastic and Reconstructive Surgery, 2003;19(1):62-67.
  12. Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D. Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. Blood, 2003;101(5):2067-2069.
  13. Trinkaus KM, Miller JP. Principles of Clinical Trials. In: The Washington Manual of Oncology, edited by R. Govindan and MA Arquette, 2002, pp. 1-10, Lippincott, Williams and Wilkins, Philadelphia.
  14. Ibrahim JE, Sweet SC, Flippin M, Dent C, Mendelhoff E, Huddleston CB, Trinkaus K and Canter C. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life. J Heart Lung Transplant, 2002;21:311-318.
  15. Custer PL, Trinkaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthalmic Plastic and Reconstructive Surgery, 2002;18(6):409-415.
  16. O'Sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC. Loss of Heterozygosity at 11q23.3 in Vasculo-invasive and Metastatic Squamous Cell Carcinoma of the Cervix. Human Pathology, 2001;32(5):475-478.
  17. Dunphy F, Dunleavy TL, Harrison BR, Trinkaus KM, Kim HJ, Stack BC Jr., Needles B, Boyd JH. Induction Paclitaxel and Carboplatin for Patients with Head and Neck Carcinoma: Analysis of 62 Patients Treated between 1994 and 1999. Cancer, 2001;91(5):940-948.
  18. Tezel G, Siegmund KD, Trinkaus K, Wax MB, Kass MA, Kolker AE. Clinical Factors Associated with Progression of Glaucomatous Optic Disc Damage in Treated Patients. Archives of Ophthalmology, 2001;119:813-818.
  19. Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, Westervelt P, Trinkaus K, Lin H-S, DiPersio J. Low Incidence of Transplantation-Related Acute Complications in Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation with a Low-Dose (550 cGy) Total Body Irradiation Conditioning Regimen. Biology of Blood and Marrow Transplantation, 2001;7:352-358.
  20. Mortimer JE, Dehdashti F, Siegel BA, Trinkaus K, Katzenellenbogen JA, Welch MJ. Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer. Journal of Clinical Oncology, 2001;19(11):2797-2803.
  21. Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman S, DiPersio JF. Treatment of Steroid-Resistant Acute Graft-versus-Host Disease with Anti-Thymocyte Globulin. Bone Marrow Transplantation, 2001;27:1059-1064.
  22. Engelgau MM, Geiss LS, Manninen DL, Orians CE, Wagner EH, Friedman NM, Hurley JS, Trinkaus KM, Shatin D, Vorst KA. Diabetes Mellitus in Managed Care: Complications and Resource Utilization. CDC Diabetes in Managed Care Work Group. American Journal of Managed Care, 2001;7(5).
  23. Khoury HJ, Adkins D, Brown R, Trinkaus KM, Vig R, Miller G, Goodnough LT, DiPersio. Does Early Treatment with High-Dose Methylprednisolone Alter the Course of Hepatic Regimen-Related Toxicity?. Bone Marrow Transplantation, 2000;25(7):737-743.
  24. Vij R, DiPersio J, Brown R, Trinkaus K, Abboud C, Meehan KR, Frenette G, Freytes C, Goodnough LT, Khoury H, Ponnuri J, Adkins D. Outcomes of High-Dose Chemotherapy and Autologous Stem Cell Transplant in Isolated Locally Recurrent Breast Cancer: A Multicenter Evaluation. Bone Marrow Transplantation, 2000;26:947-953.
  25. Khoury H, Adkins D, Brown R, Vig R, Westervelt P, Trinkaus K, Goodnough LT, DiPersio JF. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing peripheral blood stem cell transplantation. Bone Marrow Transplantation, 2000;25: 1197-1201.
  26. Trinkhuas KM, Thompson PA, Miller JP. Using SAS/InterNet Software to Support Distributed Data Entry. Proceedings of the 25th Annual Meeting of SAS Users Group International (SUGI), 2000, pp.1212-1217. SAS Institute, Cary, NC.
  27. Custer PL, Trinkaus KM. Volumetric Determination of Enucleation Implant Size. American Journal of Ophthalmology, 1999;128(4): 489-494.
  28. Adkins D, Brown R, Trinkaus K, Maziarz R, Luedke S, Freytes C, Needles B, Wienski D, Fracasso P, Pluard T, Mariconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J. Outcomes of High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Stage IIIB Inflammatory Breast Cancer. Journal of Clinical Oncology, 1999;17(7):2006-2014.
  29. Custer PL, Trinkaus KM, Fornoff J. Comparative Motility of Hydroxyapatite and Alloplastic Enucleation Implants. Ophthalmology, 1999;106(3):513-516.
  30. Khoury H, Adkins D, Trinkaus K, Brown R, Miller G, Goodnough LT, DiPersio. Treatment of Hepatic Veno-occlusive Disease with High-Dose Corticosteroids: An update on 28 Stem Cell Transplant Recipients. Blood, 1998;92(10): 276A-276A Part 1 Suppl 1.
  31. CDC Diabetes in Managed Care Work Group. Engelgau MM, Geiss LS, Manninen DL, Orians CE, Wagner EH, Friedman NM, Hurley JS, Trinkaus KM, Shatin D, Vorst KA. Use of Services by Diabetes Patients in Managed Care Organizations. Development of a diabetes surveillance system. Diabetes Care, 1998;21(12):2062-2068.
  32. Hurley JS, Frost FJ, Trinkaus KM, Buatti MC, Emmett KE. Relationship of Compliance with Hormone Replacement Therapy to Short-Term Healthcare Utilization in a Managed Care Population. American Journal of Managed Care, 1998;4(12):1691-1698.
  33. Frost FJ, Tollestrup K, Trinkaus KM, Rodgers D, Kunde T, Petersen HV, Stidley CA. Mammography Screening and Breast Cancer Tumor Size in Female Members of a Managed Care Organization. Cancer Epidemiology, Biomarkers and Prevention, 1998;7(7):585-589.
  34. Pearson L, Leith CP, Duncan MH, Chen I-M, McConnell T, Trinkaus K, Foucar K, Willman CL. Multidrug Resistance-1 (MDR1) Expression and Functional Dye/Drug Efflux is Highly Correlated with the t(8;21) Chromosomal Translocation in Pediatric Acute Myeloid Leukemia. Leukemia, 1996;10(8):1274-1282.
  35. Becker TM, Trinkaus KM, Buckley DI. Tool-Related Injuries Among Amateur and Professional Woodworkers. Occupational and Environmental Health, 1996; 38(10):1032-1035.

Chengjie Xiong

  1. Xiong C, Miller JP, McKeel DW Jr., Morris JC. Combining Correlated Diagnostic Tests - Application to Neuropathologic Diagnosis of Alzheimer's Disease. Medical Decision Making, in press.
  2. Xiong C, van Belle G, Miller JP, Morris JC. Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups. Statistics in Medicine, (in press).
  3. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. Alzheimer's Disease and Cancer. Neurology (in press).
  4. Galvin JE, Powlishta KK, Wilkins K, McKeel DW, Xiong C, Grant E, Storandt M, Morris JC. Predictors of preclinical Alzheimer's disease and dementia: a clinicopathologic study. Archives of Neurology (in press).
  5. Yu K, Zhang, S, Borecki I, Kraja A, Xiong C, Myers R, Province M. A Haplotype Similarity based Transmission/Disequilibrium Test under Founder Heterogeneity. Annual of Human Genetics (in press).
  6. Xiong C, Zhu K, Yu K. Statistical survival analysis with applications. In: Springer Handbook of Engineering Statistics (in press).
  7. Liu B, Chen D, Xiong C, Xing K. New methods for binary multiplication. International Journal of Computer Mathematics, 2005, 82 (1):13-22.
  8. Huang C, Xiong C, Kornfeld K. Measurements of age-related changes of physiological processes that predict life span of Caenorhabditis elegans. Proceedings of National Academy of Sciences of the USA, 101, 21, 8084-8089, 2004.
  9. McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L and Morris JC. Neuropathologic criteria For diagnosing Alzheimer's disease in persons with pure dementia of Alzheimer type. Journal of Neuropathology and Experimental Neuropathology, 2004; 63, 10:1028-1037.
  10. Yu K, Gu C, Province M, Xiong C, Rao DC. Genetic association mapping under founder heterogeneity via weighted haplotype similarity analysis in candidate genes. Genetic Epidemiology, 2004, 27: 182-197.
  11. Xiong C, McKeel DW, Miller JP, Morris JC. Combining correlated diagnostic tests---application to neuropathologic diagnosis of Alzheimer's disease. Medical Decision Making, 24 (6): 659-669, 2004.
  12. Xiong C, Miller JP, Feng G, Yan Y and Morris JC. Testing for Increasing Hazard Rate for the Time of Progression Associated with Alzheimer's Disease. Discrete and Continuous Dynamical Systems, B 4,3,813-821, 2004.
  13. Xiong C, Miller JP, Yan Y and Ji M. Effect of a Guarantee Time on Sample Size Determination for Testing the Ratio of Means from Two Lifetime Distributions. Journal of Biopharmaceutical Statistics, 14,1,177-188, 2004.
  14. Xiong C and Ji M. Analysis of Grouped and Censored Data from Step-stress Life Testing. IEEE Transactions on Reliability, 53,1,22-28, 2004.
  15. Ji M, Xiong C and Grundman M. Use of Mixed Effects Models to Evaluate Change Points During the Course of Cognitive Decline to AD. Journal of the Alzheimer's Disease, 5,5, 375-382, 2003.
  16. Xiong C, Yan Y, Ji M. Test of Homogeneity for Umbrella Alternatives in Dose-response Relationship. Journal of Modern Applied Statistical Methods, 2,2,389-399, 2003.
  17. Xiong C. Step-Stress Accelerated Life Testing. In: Reliability Engineering Handbook (ed. Hoang Pham), Springer-Verlag, 2003.
  18. Xiong C, Yan Y and Ji M. Sample Sizes for Comparing Means of Two Lifetime Distributions with Type II Censored Data: Application in an Aging Intervention Study. Controlled Clinical Trials, 24, 283-293, 2003.
  19. Yan Y, Hoover DR, Moore RD, and Xiong C. Multivariate Estimation of Cumulative Incidence, Prevalence and Morbidity Time of a Disease When Death Is Likely. Journal of Clinical Epidemiology, 56, 1-7, 2003.
  20. Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM. CSF sulfatide is decreased in individuals with incipient dementia. Annals of Neurology, 54, 1, 115-119, 2003.
  21. Duchek JM, Carr DB, Hunt L, Roe CM, Xiong C, Shah K, Morris JC. Longitudinal Driving Performance in Early Stage Dementia of the Alzheimer Type. Journal of the American Geriatric Society, 51, 1342-1347, 2003.
  22. Xiong C, Miller JP and Morris JC. Testing Correlation of Cognitive Decline at Adjacent Stages of Dementia. Journal of the Alzheimer's Disease, 5,5,409-418, 2003.
  23. Xiong C and El Barmi H. On Detecting Change in Likelihood Ratio Ordering. Journal of Nonparametric Statistics, 14, No 5, 555-568. 2002.
  24. Xiong C and Milliken G. Prediction for Exponential Life-times Based on Step-stress Testing. Communications in Statistics: Simulation and Computation, 31, No 4, 539-556. 2002.
  25. Xiong C. Optimum Price for a Chain of Price Setting Firms (abstract). The IMS Bulletin, 272-40, No. 2, 133-133, 2001.
  26. Robel R and Xiong C. Vegetation Structure and Invertebrate Biomass of Conventional and Sustainable Sorghum Fields in Kansas. The Prairie Naturalist, 33(1) 1-19, 2001.
  27. Xiong C and Milliken G. Changepoints in Stochastic Ordering. Communications in Statistics: Theory and Methods, 29, 2, 381-400, 2000.
  28. Xiong C. Step Stress Model with Threshold Parameter. Journal of Statistical Simulation and Computation, 63, 349-360, 1999.
  29. Xiong C and Milliken G. Step-stress Life-testing with Random Stress-change Times for Exponential Data. IEEE Transactions on Reliability, 48, 2, 141-148, 1999.
  30. Xiong C. Inferences on a Simple Step-stress Model with Type-II Censored Exponential Data. IEEE Transactions on Reliability, 47, 2, 142-146, 1998.
  31. Xiong C. Optimum Design on Step-stress Life Testing. Proceedings of the 1998 Kansas State University Conference on Applied Statistics in Agriculture, 214-225, 1998.
  32. Xiong C, Milliken G. Wavelet Nonparametric Regression with Dependent Data. Proceedings of the 1996 Kansas State University Conference on Applied Statistics in Agriculture, 162-189, 1996.
  33. Xiong C. Rescue by Satellite Communication. Science and Technology Daily, 1992.
  34. Xiong C. The Third Crisis of Mathematics. Science and Technology Daily,1990.
  35. Xiong C. Liu Hui: The Father of Chinese Mathematics. Science and Technology Daily, 1990.
  36. Xiong C. Particles from the Outer Space. Beijing Science and Technology, 1989.
  37. Xiong C. Disgraceful Incidents in the History of Mathematics. Science and Technology Daily, 1988.
  38. Xiong C. Self Medicare of Wildlife Animals. Beijing Science and Technology, 1987.
  39. Xiong C. How Does Mathematics Solve Real World Problems? Science and Technology Daily, 1986.
  40. Xiong C. Children and Nuclear Bombs. Beijing Science and Technology, 1986.
  41. Xiong C. The Past and the Present of Mathematics. Science and Technology Daily, 1985.
  42. Song X, Xiong C and Xu X. On Some Problems of Orlicz Spaces. Natural Science Journal of Xiangtan University, 87-97, 1984.